121 related articles for article (PubMed ID: 35006233)
1. Synthesis and anti-tumor activity evaluation of salinomycin C20-
Li B; Wu J; Tang L; Lian X; Li Z; Duan W; Qin T; Zhao X; Hu Y; Zhang C; Li T; Hao J; Zhang W; Zhang J; Wu S
Org Biomol Chem; 2022 Jan; 20(4):870-876. PubMed ID: 35006233
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of conformationally constrained salinomycin derivatives.
Zhang W; Wu J; Li B; Lian X; Xia J; Zhou Q; Wu S
Eur J Med Chem; 2017 Sep; 138():353-356. PubMed ID: 28688275
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Anticancer Activity of Tertiary Amides of Salinomycin and Their C20-oxo Analogues.
Czerwonka D; Urbaniak A; Sobczak S; Piña-Oviedo S; Chambers TC; Antoszczak M; Huczyński A
ChemMedChem; 2020 Jan; 15(2):236-246. PubMed ID: 31702860
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of salinomycin-hydroxamic acid conjugates.
Li B; Wu J; Zhang W; Li Z; Chen G; Zhou Q; Wu S
Bioorg Med Chem Lett; 2017 Apr; 27(7):1624-1626. PubMed ID: 28262526
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
Zhang Q; Dong J; Cui J; Huang G; Meng Q; Li S
Chem Pharm Bull (Tokyo); 2018; 66(6):612-619. PubMed ID: 29863062
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
Wang R; Zhang X; Song H; Zhou S; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel steroidal 5α,8α-epidioxyandrost-6-ene-3β-ol-17-(O-phenylacetamide)oxime derivatives as potential anticancer agents.
Bu M; Cao T; Li H; Guo M; Yang BB; Zeng C; Zhou Y; Zhang N; Hu L
Bioorg Med Chem Lett; 2017 Aug; 27(16):3856-3861. PubMed ID: 28666736
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives.
Latif AD; Gonda T; Vágvölgyi M; Kúsz N; Kulmány Á; Ocsovszki I; Zomborszki ZP; Zupkó I; Hunyadi A
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052551
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antiproliferative and antibacterial activity of new amides of salinomycin.
Antoszczak M; Maj E; Stefańska J; Wietrzyk J; Janczak J; Brzezinski B; Huczyński A
Bioorg Med Chem Lett; 2014 Apr; 24(7):1724-9. PubMed ID: 24631190
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
[TBL] [Abstract][Full Text] [Related]
12. Semisynthesis of SY-1 for investigation of breast cancer stem cell selectivity of C-ring-modified salinomycin analogues.
Huang X; Borgström B; Månsson L; Persson L; Oredsson S; Hegardt C; Strand D
ACS Chem Biol; 2014 Jul; 9(7):1587-94. PubMed ID: 24841425
[TBL] [Abstract][Full Text] [Related]
13. Biological activity of doubly modified salinomycin analogs - Evaluation in vitro and ex vivo.
Antoszczak M; Urbaniak A; Delgado M; Maj E; Borgström B; Wietrzyk J; Huczyński A; Yuan Y; Chambers TC; Strand D
Eur J Med Chem; 2018 Aug; 156():510-523. PubMed ID: 30025346
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiproliferative activity of some androstene oximes and their O-alkylated derivatives.
Acharya PC; Bansal R
Arch Pharm (Weinheim); 2014 Mar; 347(3):193-9. PubMed ID: 24343881
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Antiproliferative Activity of Silybin Conjugates with Salinomycin and Monensin.
Antoszczak M; Klejborowska G; Kruszyk M; Maj E; Wietrzyk J; Huczyński A
Chem Biol Drug Des; 2015 Dec; 86(6):1378-86. PubMed ID: 26058448
[TBL] [Abstract][Full Text] [Related]
16. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
17. Novel
Kozłowska J; Grela E; Baczyńska D; Grabowiecka A; Anioł M
Molecules; 2019 Feb; 24(4):. PubMed ID: 30769816
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative activity of salinomycin and its derivatives.
Huczyński A; Janczak J; Antoszczak M; Wietrzyk J; Maj E; Brzezinski B
Bioorg Med Chem Lett; 2012 Dec; 22(23):7146-50. PubMed ID: 23079523
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of salinomycin triazole analogues as anticancer agents.
Huang M; Deng Z; Tian J; Liu T
Eur J Med Chem; 2017 Feb; 127():900-908. PubMed ID: 27876192
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and antitumor activity evaluation of steroidal oximes.
Gomes AR; Pires AS; Abrantes AM; Gonçalves AC; Costa SC; Varela CL; Silva ET; Botelho MF; Roleira FMF
Bioorg Med Chem; 2021 Sep; 46():116360. PubMed ID: 34425478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
